Tag Archives: Anthony Vendetti

Celsius Holdings Inc (CELH) Gets a Buy Rating from Maxim Group

In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Celsius Holdings Inc (CELH – Research Report), with a price target of $8. The company’s shares opened today at $4.75. Vendetti wrote: “Market open, CELH

Craft Brewers Alliance (BREW) Gets a Buy Rating from Maxim Group

Maxim Group analyst Anthony Vendetti maintained a Buy rating on Craft Brewers Alliance (BREW – Research Report) on August 7 and set a price target of $21. The company’s shares closed yesterday at $15.74. Vendetti commented: “Market close, BREW reported

Landec Corp (LNDC) Receives a Buy from Maxim Group

Maxim Group analyst Anthony Vendetti maintained a Buy rating on Landec Corp (LNDC – Research Report) on July 30 and set a price target of $17. The company’s shares closed yesterday at $11.17. Vendetti noted: “Market close, LNDC reported F4Q19

Daxor Corp (DXR) Receives a Buy from Maxim Group

Maxim Group analyst Anthony Vendetti maintained a Buy rating on Daxor Corp (DXR – Research Report) yesterday and set a price target of $22. The company’s shares closed yesterday at $9.85. Vendetti noted: “Daxor has a substantial commercial opportunity with

Maxim Group Sticks to Its Buy Rating for Landec Corp (LNDC)

In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Landec Corp (LNDC – Research Report), with a price target of $17. The company’s shares closed yesterday at $9.66, close to its 52-week low of

Maxim Group Keeps a Hold Rating on Applied DNA Sciences (APDN)

Maxim Group analyst Anthony Vendetti maintained a Hold rating on Applied DNA Sciences (APDN – Research Report) yesterday. The company’s shares opened today at $0.59. Vendetti commented: “2019, APDN announced that its cannabis partner, TheraCann International (private), secured an agreement